Open Access Open Access  Restricted Access Subscription Access

Understanding Arterial Thrombo Embolic Diseases: Causes, Symptoms, and Treatment

Guruprasad M., Muralinath E., Singh H. S., Vijay Digamber D., Shraddha D., Lalit Kumar S., Kalyan C., Archana Jain

Abstract


Arterial thrombosis embolic diseases encompass a spectrum of conditions manifested by the formation of blood clots within arteries, resulting. The obstruction of blood flow causes for arterial thrombo embolism diseases include atherosclerosis, hypertension, hyper lipidemia, smoking, diabetes and obesity. Symptoms include chest pain, numbness, weakness of face, arm or leg and shortness of breath. Treatment is based on anti platelet medications, anti coagulant, thrombosis lytic therapy and per cutaneous interventions. Finally it is concluded that by implementing these preventive strategies and effectively managing underlying risk factors, individuals can reduce their likelihood or developing arterial thrombosis embolism diseases and enhance their overall cardio vascular health.


Full Text:

PDF

References


Mackman, N. (2008). Triggers, targets and treatments for thrombosis. Nature, 451(7181), 914-918.

Prandoni, P. (2017). Venous and arterial thrombosis: is there a link?. Thrombosis and Embolism: from Research to Clinical Practice: Volume 1, 273-283.

Lowe, G. D. (2004). Venous and arterial thrombosis: epidemiology and risk factors at various ages. Maturitas, 47(4), 259-263.

Favaloro, E. J., Franchini, M., & Lippi, G. (2014, September). Aging hemostasis: changes to laboratory markers of hemostasis as we age—a narrative review. In Seminars in thrombosis and hemostasis (Vol. 40, No. 06, pp. 621-633). Thieme Medical Publishers.

Favaloro, E. J., Franchini, M., & Lippi, G. (2014, September). Aging hemostasis: changes to laboratory markers of hemostasis as we age—a narrative review. In Seminars in thrombosis and hemostasis (Vol. 40, No. 06, pp. 621-633). Thieme Medical Publishers.

Heit, J. A., Spencer, F. A., & White, R. H. (2016). The epidemiology of venous thromboembolism. Journal of thrombosis and thrombolysis, 41, 3-14.

Liao, S., Woulfe, T., Hyder, S., Merriman, E., Simpson, D., & Chunilal, S. (2014). Incidence of venous thromboembolism in different ethnic groups: a regional direct comparison study. Journal of Thrombosis and Haemostasis, 12(2), 214-219.

Lee, C. H., Lin, L. J., Cheng, C. L., YANG, Y. H. K., Chen, J. Y., & Tsai, L. M. (2010). Incidence and cumulative recurrence rates of venous thromboembolism in the Taiwanese population. Journal of Thrombosis and Haemostasis, 8(7), 1515-1523.

Mosevoll, K. A., Johansen, S., Wendelbo, Ø., Nepstad, I., Bruserud, Ø., & Reikvam, H. (2018). Cytokines, adhesion molecules, and matrix metalloproteases as predisposing, diagnostic, and prognostic factors in venous thrombosis. Frontiers in medicine, 5, 147.

Insull Jr, W. (2009). The pathology of atherosclerosis: plaque development and plaque responses to medical treatment. The American journal of medicine, 122(1), S3-S14.

Streiff, M. B., Agnelli, G., Connors, J. M., Crowther, M., Eichinger, S., Lopes, R., ... & Ansell, J. (2016). Guidance for the treatment of deep vein thrombosis and pulmonary embolism. Journal of thrombosis and thrombolysis, 41, 32-67.

Lim, W., Le Gal, G., Bates, S. M., Righini, M., Haramati, L. B., Lang, E., ... & Mustafa, R. A. (2018). American Society of Hematology 2018 guidelines for management of venous thromboembolism: diagnosis of venous thromboembolism. Blood advances, 2(22), 3226-3256.

Becattini, C., & Agnelli, G. (2016). Treatment of venous thromboembolism with new anticoagulant agents. Journal of the American College of Cardiology, 67(16), 1941-1955.

Winter, M. P., Schernthaner, G. H., & Lang, I. M. (2017). Chronic complications of venous thromboembolism. Journal of Thrombosis and Haemostasis, 15(8), 1531-1540.

Witt, D. M., Nieuwlaat, R., Clark, N. P., Ansell, J., Holbrook, A., Skov, J., ... & Guyatt, G. (2018). American Society of Hematology 2018 guidelines for management of venous thromboembolism: optimal management of anticoagulation therapy. Blood advances, 2(22), 3257-3291.

Schünemann, H. J., Cushman, M., Burnett, A. E., Kahn, S. R., Beyer-Westendorf, J., Spencer, F. A., ... & Wiercioch, W. (2018). American Society of Hematology 2018 guidelines for management of venous thromboembolism: prophylaxis for hospitalized and nonhospitalized medical patients. Blood advances, 2(22), 3198-3225.

Goktay, A. Y., & Senturk, C. (2017). Endovascular treatment of thrombosis and embolism. Thrombosis and Embolism: from Research to Clinical Practice: Volume 1, 195-213.

Reitter-Pfoertner, S., Waldhoer, T., Mayerhofer, M., Eigenbauer, E., Ay, C., Mannhalter, C., ... & Pabinger, I. (2013). The influence of thrombophilia on the long-term survival of patients with a history of venous thromboembolism. Thrombosis and haemostasis, 109(01), 79-84.

Cohen, A. T., Agnelli, G., Anderson, F. A., Arcelus, J. I., Bergqvist, D., Brecht, J. G., ... & VTE Impact Assessment Group in Europe (VITAE. (2007). Venous thromboembolism (VTE) in Europe. Thrombosis and haemostasis, 98(10), 756-764.

Shbaklo, H., & Kahn, S. R. (2008). Long-term prognosis after deep venous thrombosis. Current opinion in hematology, 15(5), 494-498.

Courtney, D.M., Sasser, H.C., Pincus, C.L., Kline, J.A. (2001). Pulseless electrical activity with witnessed arrest as a predictor of sudden death from massive pulmonary embolism in outpatients. Resuscitation, 49(3), 265-72.

Kucher, N., & Goldhaber, S. Z. (2005). Management of massive pulmonary embolism. Circulation, 112(2), e28-e32.

Kiely, D. G., Kennedy, N. S., Pirzada, O., Batchelor, S. A., Struthers, A. D., & Lipworth, B. J. (2005). Elevated levels of natriuretic peptides in patients with pulmonary thromboembolism. Respiratory medicine, 99(10), 1286-1291.

Henzler, T., Roeger, S., Meyer, M., Schoepf, U. J., Nance, J. W., Haghi, D., ... & Fink, C. (2012). Pulmonary embolism: CT signs and cardiac biomarkers for predicting right ventricular dysfunction. European Respiratory Journal, 39(4), 919-926.

Meyer, T., Binder, L., Hruska, N., Luthe, H., & Buchwald, A. B. (2000). Cardiac troponin I elevation in acute pulmonary embolism is associated with right ventricular dysfunction. Journal of the American College of Cardiology, 36(5), 1632-1636.

Konstantinides, S., Geibel, A., Olschewski, M., Kasper, W., Hruska, N., Jäckle, S., & Binder, L. (2002). Importance of cardiac troponins I and T in risk stratification of patients with acute pulmonary embolism. Circulation, 106(10), 1263-1268.

Horlander, K. T., & Leeper, K. V. (2003). Troponin levels as a guide to treatment of pulmonary embolism. Current opinion in pulmonary medicine, 9(5), 374-377.

Righini, M., Van Es, J., Den Exter, P. L., Roy, P. M., Verschuren, F., Ghuysen, A., ... & Le Gal, G. (2014). Age-adjusted D-dimer cutoff levels to rule out pulmonary embolism: the ADJUST-PE study. Jama, 311(11), 1117-1124.

Rodger, M., Makropoulos, D., Turek, M., Quevillon, J., Raymond, F., Rasuli, P., & Wells, P. S. (2000). Diagnostic value of the electrocardiogram in suspected pulmonary embolism. American Journal of Cardiology, 86(7), 807-809.

Worsley, D. F., Alavi, A., Aronchick, J. M., Chen, J. T., Greenspan, R. H., & Ravin, C. E. (1993). Chest radiographic findings in patients with acute pulmonary embolism: observations from the PIOPED Study. Radiology, 189(1), 133-136.

Ghaye, B., Szapiro, D., Mastora, I., Delannoy, V., Duhamel, A., Remy, J., & Remy-Jardin, M. (2001). Peripheral pulmonary arteries: how far in the lung does multi-detector row spiral CT allow analysis?. Radiology, 219(3), 629-636.

Stein, P. D., Fowler, S. E., Goodman, L. R., Gottschalk, A., Hales, C. A., Hull, R. D., ... & Woodard, P. K. (2006). Multidetector computed tomography for acute pulmonary embolism. New England Journal of Medicine, 354(22), 2317-2327.

Becattini, C., Agnelli, G., Vedovati, M. C., Pruszczyk, P., Casazza, F., Grifoni, S., ... & Duranti, M. (2011). Multidetector computed tomography for acute pulmonary embolism: diagnosis and risk stratification in a single test. European heart journal, 32(13), 1657-1663.

Reid, J. H., Coche, E. E., Inoue, T., Kim, E. E., Dondi, M., Watanabe, N., ... & International Atomic Energy Agency Consultants’ Group. (2009). Is the lung scan alive and well? Facts and controversies in defining the role of lung scintigraphy for the diagnosis of pulmonary embolism in the era of MDCT. European journal of nuclear medicine and molecular imaging, 36, 505-521.

Glaser, J. E., Chamarthy, M., Haramati, L. B., Esses, D., & Freeman, L. M. (2011). Successful and safe implementation of a trinary interpretation and reporting strategy for V/Q lung scintigraphy. Journal of Nuclear Medicine, 52(10), 1508-1512.

Anderson, D. R., Kahn, S. R., Rodger, M. A., Kovacs, M. J., Morris, T., Hirsch, A., ... & Wells, P. S. (2007). Computed tomographic pulmonary angiography vs ventilation-perfusion lung scanning in patients with suspected pulmonary embolism: a randomized controlled trial. Jama, 298(23), 2743-2753.

Sostman, H. D., Stein, P. D., Gottschalk, A., Matta, F., Hull, R., & Goodman, L. (2008). Acute pulmonary embolism: sensitivity and specificity of ventilation-perfusion scintigraphy in PIOPED II study. Radiology, 246(3), 941-946.

Pioped Investigators. (1990). Value of the ventilation/perfusion scan in acute pulmonary embolism. Results of the prospective investigation of pulmonary embolism diagnosis (PIOPED). Jama, 263(20), 2753-2759.

Wittram, C., Waltman, A. C., Shepard, J. A. O., Halpern, E., & Goodman, L. R. (2007). Discordance between CT and angiography in the PIOPED II study. Radiology, 244(3), 883-889.

Stein, P. D., Chenevert, T. L., Fowler, S. E., Goodman, L. R., Gottschalk, A., Hales, C. A., ... & PIOPED III (Prospective Investigation of Pulmonary Embolism Diagnosis III) Investigators*. (2010). Gadolinium-enhanced magnetic resonance angiography for pulmonary embolism: a multicenter prospective study (PIOPED III). Annals of internal medicine, 152(7), 434-443.

Grifoni, S., Olivotto, I., Cecchini, P., Pieralli, F., Camaiti, A., Santoro, G., ... & Berni, G. (2000). Short-term clinical outcome of patients with acute pulmonary embolism, normal blood pressure, and echocardiographic right ventricular dysfunction. Circulation, 101(24), 2817-2822.

Torbicki, A., Kurzyna, M., Ciurzynski, M., Pruszczyk, P., Pacho, R., Kuch-Wocial, A., & Szulc, M. (1999). Proximal pulmonary emboli modify right ventricular ejection pattern. European Respiratory Journal, 13(3), 616-621.

Bova, C., Greco, F., Misuraca, G., Serafini, O., Crocco, F., Greco, A., & Noto, A. (2003). Diagnostic utility of echocardiography in patients with suspected pulmonary embolism. The American journal of emergency medicine, 21(3), 180-183.

Wolfe, M. W., Lee, R. T., Feldstein, M. L., Parker, J. A., Come, P. C., & Goldhaber, S. Z. (1994). Prognostic significance of right ventricular hypokinesis and perfusion lung scan defects in pulmonary embolism. American heart journal, 127(5), 1371-1375.

Kurzyna, M., Torbicki, A., Pruszczyk, P., Burakowska, B., Fijałkowska, A., Kober, J., ... & Wawrzyńska, L. (2002). Disturbed right ventricular ejection pattern as a new Doppler echocardiographic sign of acute pulmonary embolism. The American journal of cardiology, 90(5), 507-511.


Refbacks

  • There are currently no refbacks.